FRESENIUS MEDICAL CARE-ADR (FMS) Forecast, Price Target & Analyst Ratings

NYSE:FMS • US3580291066

Current stock price

23.43 USD
+0.68 (+2.99%)
At close:
23.43 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FRESENIUS MEDICAL CARE-ADR (FMS).

Forecast Snapshot

Consensus Price Target

Price Target
$27.20
+ 16.10% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
€0.49
Revenue Estimate
4.726B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
65.93%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$27.20
Upside
+ 16.10%
From current price of $23.43 to mean target of $27.20, Based on 27 analyst forecasts
Low
$13.31
Median
$28.48
High
$38.68

Price Target Revisions

1 Month
0.00%
3 Months
-1.95%

Price Target Summary

27 Wall Street analysts provided a forecast for the next 12 months for FMS. The average price target is 27.2 USD. This implies a price increase of 16.1% is expected in the next year compared to the current price of 23.43.
The average price target has been revised downward by 1.95% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

FMS Current Analyst RatingFMS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

FMS Historical Analyst RatingsFMS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
65.93%
FMS was analyzed by 27 analysts. The buy percentage consensus is at 66. So analysts seem to be have mildly positive about FMS.
In the previous month the buy percentage consensus was at a similar level.
FMS was analyzed by 27 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-09-02UBSDowngrade Neutral -> Sell
2025-05-12Truist SecuritiesMaintains Hold -> Hold
2025-01-06Truist SecuritiesMaintains Hold -> Hold
2024-10-07Truist SecuritiesMaintains Hold -> Hold
2024-07-31Truist SecuritiesMaintains Hold -> Hold
2024-05-15Truist SecuritiesMaintains Hold -> Hold
2023-11-24HSBCUpgrade Reduce -> Hold
2023-10-11Truist SecuritiesMaintains Hold -> Hold
2023-07-13Truist SecuritiesMaintains Hold -> Hold
2023-05-10Truist SecuritiesMaintains Hold -> Hold
2023-04-13Truist SecuritiesMaintains Hold
2023-02-23Truist SecuritiesMaintains Hold
2022-06-22Truist SecuritiesMaintains Hold
2021-11-23HSBCInitiate Hold
2021-11-17RBC CapitalMaintains Sector Perform
2021-11-11JefferiesUpgrade Underperform -> Hold
2021-08-11JPMorgan ChaseInitiate
2021-08-06Goldman SachsInitiate
2021-07-24JefferiesInitiate
2021-07-23JefferiesInitiate
2021-07-22Goldman SachsInitiate
2021-07-21Goldman SachsInitiate
2021-07-20JPMorgan ChaseInitiate
2021-07-20Berenberg BankInitiate
2021-07-14Morgan StanleyInitiate

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
€0.49
Revenue Estimate
4.726B
Revenue Q2Q
-3.18%
EPS Q2Q
14.51%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
-1.21%
Revenue (3 Months)
-5.93%
EPS (1 Month)
21.80%
EPS (3 Months)
33.21%

Next Earnings Summary

FMS is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0.49 USD and the consensus revenue estimate is 4.73B USD.
The next earnings revenue estimate has been revised downward by 5.93% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
FMS revenue by date.FMS revenue by date.
19.454B
0.29%		19.336B
-0.61%		19.628B
1.51%		19.716B
0.45%		20.458B
3.76%		21.017B
2.73%		22.651B
7.77%		23.679B
4.54%		24.707B
4.34%		25.66B
3.86%		26.63B
3.78%
EBITDA
YoY % growth
FMS ebitda by date.FMS ebitda by date.
3.03B
-3.03%		3.008B
-0.73%		3.266B
8.57%		3.608B
10.47%		3.815B
5.74%		4.015B
5.24%		4.185B
4.23%		4.271B
2.05%		4.962B
16.18%		5.14B
3.59%		5.322B
3.54%
EBIT
YoY % growth
FMS ebit by date.FMS ebit by date.
1.278B
-0.65%		1.266B
-0.97%		1.766B
39.46%		2.024B
14.64%		2.236B
10.47%		2.408B
7.69%		2.977B
23.63%		3.203B
7.59%		3.537B
10.43%		3.676B
3.93%		3.82B
3.92%
Operating Margin
FMS operating margin by date.FMS operating margin by date.
6.57%6.55%9.00%10.27%10.93%11.46%13.14%13.53%14.32%14.33%14.34%
EPS
YoY % growth
FMS eps by date.FMS eps by date.
1.31
-17.23%		1.66
26.66%		2.20
32.00%		2.05
-6.53%		2.29
11.46%		2.67
16.58%		3.04
14.03%		3.38
11.24%		3.46
2.27%		3.72
7.49%		3.95
6.15%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		0.49
14.51%		0.51
9.35%		0.54
-3.81%		0.59
-20.04%
Revenue
Q2Q % growth		4.726B
-3.18%		4.837B
0.94%		4.987B
2.09%		5.138B
1.34%
EBITDA
Q2Q % growth		802.46M
6.76%		831.25M
-28.06%		886.05M
-43.84%		817.73M
-60.53%
EBIT
Q2Q % growth		487.61M
36.47%		523.24M
35.59%		548.78M
21.71%		548.49M
-4.01%

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

FMS Yearly Revenue VS EstimatesFMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
FMS Yearly EPS VS EstimatesFMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
6.69%
EPS Next 5 Year
9.03%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
2.08%
Revenue Next 5 Year
3.69%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
24.11%
EBIT Next 5 Year
15.26%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

FRESENIUS MEDICAL CARE-ADR / FMS Forecast FAQ

What is the price target for FMS stock?

27 analysts have analysed FMS and the average price target is 27.2 USD. This implies a price increase of 16.1% is expected in the next year compared to the current price of 23.43.

Can you provide the upcoming earnings date for FRESENIUS MEDICAL CARE-ADR?

FRESENIUS MEDICAL CARE-ADR (FMS) will report earnings on 2026-05-05.

Can you provide the consensus estimates for FRESENIUS MEDICAL CARE-ADR next earnings?

The consensus EPS estimate for the next earnings of FRESENIUS MEDICAL CARE-ADR (FMS) is 0.49 USD and the consensus revenue estimate is 4.73B USD.

What is the expected long term growth rate for FRESENIUS MEDICAL CARE-ADR (FMS)?

The expected long term growth rate for FRESENIUS MEDICAL CARE-ADR (FMS) is 2.08%.